Myeloid cell expressed proprotein convertase FURIN attenuates inflammation

Oncotarget

Volumn 7, Issue 34, 2016, Pages 54392-54404

  Cordova, Zuzet Martinez ^a   Grönholm, Anna ^a   Kytölä, Ville ^a   Taverniti, Valentina ^b   Hämäläinen, Sanna ^a   Aittomäki, Saara ^a   Niininen, Wilhelmiina ^a   Junttila, Ilkka ^a,c   Ylipää, Antti ^a   Nykter, Matti ^a   Pesu, Marko ^a,d  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b UNIVERSITY OF MILAN   (Italy)

^c PIRKANMAA HOSPITAL DISTRICT   (Finland)

^d TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cytokine; FURIN; Immune response; Immunity; Immunology and Microbiology Section; LysM; Macrophage; TGF 1

Indexed keywords

ARGINASE 1; CYTOKINE; FURIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARG1 GENE; ARTICLE; BONE MARROW CELL; CELL COUNT; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE DELETION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENOME; IN VIVO STUDY; MACROPHAGE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; NOS2 GENE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN CELL; UPREGULATION; ANIMAL; BLOOD; C57BL MOUSE; ENZYMOLOGY; INFLAMMATION; METABOLISM; PHYSIOLOGY; SECRETION (PROCESS);

ADAM17 PROTEIN; ANIMALS; CASPASE 1; FURIN; GENE EXPRESSION REGULATION; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, INBRED C57BL; MYELOID CELLS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84983535222     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11106     Document Type: Article

References (68)

1. Taylor NA, Van De Ven WJ, Creemers JW. Curbing activation: proprotein convertases in homeostasis and pathology. FASEB J. 2003; 17: 1215-1227.
2. Seidah NG, Prat A. The biology and therapeutic targeting of the proprotein convertases. Nature Reviews Drug Discovery. 2012; 11: 367-383.
3. Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol. 2002; 3: 753-766.
4. Roebroek AJ, Taylor NA, Louagie E, Pauli I, Smeijers L, Snellinx A, Lauwers A, Van de Ven WJ, Hartmann D, Creemers JW. Limited redundancy of the proprotein convertase furin in mouse liver. J Biol Chem. 2004; 279: 53442-53450.
5. Kim W, Essalmani R, Szumska D, Creemers JW, Roebroek AJ, D'Orleans-Juste P, Bhattacharya S, Seidah NG, Prat A. Loss of endothelial furin leads to cardiac malformation and early postnatal death. Mol Cell Biol. 2012; 32: 3382-3391
6. Pesu M, Watford WT, Wei L, Xu L, Fuss I, Strober W, Andersson J, Shevach EM, Quezado M, Bouladoux N. T-cell-expressed proprotein convertase furin is essential for maintenance of peripheral immune tolerance. Nature. 2008; 455: 246-250.
7. Turpeinen H, Seppälä I, Lyytikäinen LP, Raitoharju E, Hutri-Kähönen N, Levula M, Oksala N, Waldenberger M, Klopp N, Illig T, Mononen N, Laaksonen R, Raitakari O, et al. A Genome-wide Expression Quantitative Trait Loci Analysis of Proprotein Convertase Subtilisin/Kexin Enzymes Identifies a Novel Regulatory Gene Variant for FURIN Expression and Blood Pressure. Hum Genet. 2015; 134: 627-36.
8. Couture F, D'Anjou F, Desjardins R, Boudreau F, Day R. Role of proprotein convertases in prostate cancer progression. Neoplasia. 2012; 14: 1032-42.
9. Senzer N, Barve M, Kuhn J, Melnyk A, Beitsch P, Lazar M, Lifshitz S, Magee M, Oh J, Mill SW, Bedell C, Higgs C, Kumar P, et al. Phase I Trial of "bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell" vaccine (FANG) in advanced cancer Mol Ther. 2012; 20: 679-686.
10. Turpeinen H, Raitoharju E, Oksanen A, Oksala N, Levula M, Lyytikäinen L, Järvinen O, Creemers JW, Kähönen M, Laaksonen R. Proprotein convertases in human atherosclerotic plaques: the overexpression of FURIN and its substrate cytokines BAFF and APRIL. Atherosclerosis. 2011; 219: 799-806.
11. Pesu M, Muul L, Kanno Y, O'Shea JJ. Proprotein convertase furin is preferentially expressed in T helper 1 cells and regulates interferon gamma. Blood. 2006; 108: 983-985.
12. Ortutay Z, Oksanen A, Aittomaki S, Ortutay C, Pesu M. Proprotein convertase FURIN regulates T cell receptorinduced transactivation. J Leukoc Biol. 2015; 98: 73-83.
13. Oksanen A, Aittomaki S, Jankovic D, Ortutay Z, Pulkkinen K, Hamalainen S, Rokka A, Corthals GL, Watford WT, Junttila I, O'Shea JJ, Pesu M. Proprotein convertase FURIN constrains Th2 differentiation and is critical for host resistance against Toxoplasma gondii. J Immunol. 2014; 193: 5470-5479.
14. Levesque C, Couture F, Kwiatkowska A, Desjardins R, Guerin B, Neugebauer WA, Day R. PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation. Oncotarget. 2015; 6: 3680-3693. doi: 10.18632/oncotarget.2918.
15. Couture F, Kwiatkowska A, Dory YL, Day R. Therapeutic uses of furin and its inhibitors: a patent review. Expert Opin Ther Pat. 2015; 25: 379-396.
16. Siegfried G, Basak A, Cromlish JA, Benjannet S, Marcinkiewicz J, Chretien M, Seidah NG, Khatib A. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest. 2003; 111: 1723-1732.
17. Lansac G, Dong W, Dubois CM, Benlarbi N, Afonso C, Fournier I, Salzet M, Day R.J. Lipopolysaccharide mediated regulation of neuroendocrine associated proprotein convertases and neuropeptide precursor processing in the rat spleen. Neuroimmunol. 2006; 171:57-71.
18. Dutta P, Hoyer FF, Grigoryeva LS, Sager HB, Leuschner F, Courties G, Borodovsky A, Novobrantseva T, Ruda VM, Fitzgerald K, Iwamoto Y, Wojtkiewicz G, Sun Y, et al. Macrophages retain hematopoietic stem cells in the spleen via VCAM. J Exp Med. 2015; 212: 497-512.
19. Martinez-Pomares L, Gordon S Trends Immunol. CD169+ macrophages at the crossroads of antigen presentation. Trends Immunol. 2012; 33:66-70.
20. McGaha TL, Chen Y, Ravishankar B, van Rooijen N, Karlsson MC. Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen. Blood. 2011; 117: 5403-5412.
21. Refaie S, Gagnon S, Gagnon H, Desjardins R, D'Anjou F, D'Orleans-Juste P, Zhu X, Steiner DF, Seidah NG, Lazure C, Salzet M, Day R. Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion. J Biol Chem. 2012; 287: 14703-14717
22. Decroly E, Benjannet S, Savaria D, Seidah NG. Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160. FEBS Lett. 1997; 405: 68-72.
23. Opal SM, Artenstein AW, Cristofaro PA, Jhung JW, Palardy JE, Parejo NA, Lim YP. Inter-alpha-inhibitor proteins are endogenous furin inhibitors and provide protection against experimental anthrax intoxication. Infect Immun. 2005; 73: 5101-5105.
24. Garten W, Braden C, Arendt A, Peitsch C, Baron J, Lu Y, Pawletko K, Hardes K, Steinmetzer T, Böttcher-Friebertshäuser E. Influenza virus activating host proteases: Identification, localization and inhibitors as potential therapeutics. Eur J Cell Biol. 2015; 94: 375-83.
25. Shiryaev SA, Remacle AG, Ratnikov BI, Nelson NA, Savinov AY, Wei G, Bottini M, Rega MF, Parent A, Desjardins R, Fugere M, Day R, Sabet M, et al. Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens. J Biol Chem. 2007; 282: 20847-20853.
26. Clausen B, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999; 8: 265-277.
27. Leonhardt RM, Fiegl D, Rufer E, Karger A, Bettin B, Knittler MR. Post-endoplasmic reticulum rescue of unstable MHC class I requires proprotein convertase PC7. J Immunol. 2010; 184: 2985-2998.
28. Kumar A, Singh S, Ahirwar SK, Nath G. Proteomics-based identification of plasma proteins and their association with the host-pathogen interaction in chronic typhoid carriers. Int J Infect Dis. 2014; 19: 59-66.
29. Krebsbach PH, Kuznetsov SA, Bianco P, Robey PG. Bone marrow stromal cells: characterization and clinical application. Crit Rev Oral Biol Med. 1999; 10: 165-181.
30. Ohsugi T, Kumasaka T. Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice. PLoS One. 2011; 6: e18518.
31. Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009; 27: 621-668.
32. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, Hill S, Turner ML, Karp BI, et al. Neonatalonset multisystem inflammatory disease responsive to interleukin-1 inhibition. N Engl J Med. 2006; 355: 581-592.
33. Turpeinen H, Oksanen A, Kivinen V, Kukkurainen S, Uusimaki A, Ramet M, Parikka M, Hytonen VP, Nykter M, Pesu M. Proprotein convertase subtilisin/kexin type 7 (PCSK7) is essential for the zebrafish development and bioavailability of transforming growth factor beta1a (TGFbeta1a). J Biol Chem. 2013; 288: 36610-36623.
34. Gong D, Farley K, White M, Hartshorn KL, Benarafa C, Remold-O'Donnell E. Critical role of serpinB1 in regulating inflammatory responses in pulmonary influenza infection. J Infect Dis. 2011; 204: 592-600.
35. Udofa EA, Stringer BW, Gade P, Mahony D, Buzza MS, Kalvakolanu DV, Antalis TM. The transcription factor C/EBP-mediates constitutive and LPS-inducible transcription of murine SerpinB2. PLoS One. 2013; 8: e57855.
36. Feingold KR, Moser A, Shigenaga JK, Grunfeld C. Inflammation stimulates niacin receptor (GPR109A/HCA2) expression in adipose tissue and macrophages. J Lipid Res. 2014; 55:2501-8.
37. Piao C, Cai L, Qiu S, Jia L, Song W, Du J. Complement 5a Enhances Hepatic Metastases of Colon Cancer via Monocyte Chemoattractant Protein-1-Mediated Inflammatory Cell Infiltration. J Biol Chem. 2015; 290: 10667-76.
38. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, Goerdt S, Gordon S, Hamilton JA, Ivashkiv LB, Lawrence T, Locati M, Mantovani A, Martinez FO, et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014; 41: 14-20.
39. Gundra UM, Girgis NM, Ruckerl D, Jenkins S, Ward LN, Kurtz ZD, Wiens KE, Tang MS, Basu-Roy U, Mansukhani A, Allen JE, Loke P. Alternatively activated macrophages derived from monocytes and tissue macrophages are phenotypically and functionally distinct. Blood. 2014; 123: e110-22.
40. Yoshida K, Maekawa T, Zhu Y, Renard-Guillet C, Chatton B, Inoue K, Uchiyama T, Ishibashi K, Yamada T, Ohno N, Shirahige K, Okada-Hatakeyama M, Ishii S. The transcription factor ATF7 mediates lipopolysaccharideinduced epigenetic changes in macrophages involved in innate immunological memory. Nat Immunol. 2015; 16: 1034-43.
41. Blanchette F, Day R, Dong W, Laprise MH, Dubois CM. TGFbeta1 regulates gene expression of its own converting enzyme furin. J Clin Invest. 1997; 99: 1974-1983.
42. Ko TC, Sheng HM, Reisman D, Thompson EA, Beauchamp RD. Transforming growth factor-beta 1 inhibits cyclin D1 expression in intestinal epithelial cells. Oncogene. 1995; 10: 177-184.
43. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011; 11: 723-737.
44. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, et al. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009; 325: 612-616.
45. Grainger JR, Wohlfert EA, Fuss IJ, Bouladoux N, Askenase MH, Legrand F, Koo LY, Brenchley JM, Fraser ID, Belkaid Y. Inflammatory monocytes regulate pathologic responses to commensals during acute gastrointestinal infection. Nat Med. 2013; 19: 713-721.
46. Mehta A, Brewington R, Chatterji M, Zoubine M, Kinasewitz GT, Peer GT, Chang AC, Taylor Jr FB, Shnyra A. Infection-induced modulation of m1 and m2 phenotypes in circulating monocytes: role in immune monitoring and early prognosis of sepsis. Shock. 2004; 22: 423-430.
47. López-Bojórquez LN, Dehesa AZ, Reyes-Terán G. Molecular mechanisms involved in the pathogenesis of septic shock. Arch Med Res. 2004; 35: 465-479.
48. Hipp MM, Shepherd D, Booth S, Waithe D, Reis e Sousa C, Cerundolo V. The Processed Amino-Terminal Fragment of Human TLR7 Acts as a Chaperone to direct Human TLR7 into Endosomes. J Immunol. 2015; 194: 5417-5425.
49. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001; 410: 1103-7.
50. Russell TD, Yan Q, Fan G, Khalifah AP, Bishop DK, Brody SL, Walter MJ. IL-12 p40 homodimer-dependent macrophage chemotaxis and respiratory viral inflammation are mediated through IL-12 receptor beta 1. J Immunol. 2003; 171: 6866-74.
51. Mattiola I, Pesant M, Tentorio PF, Molgora M, Marcenaro E, Lugli E, Locati M, Mavilio D. Priming of Human Resting NK Cells by Autologous M1 Macrophages via the Engagement of IL-1, IFN-, and IL-15 Pathways. J Immunol. 2015; 195: 2818-28.
52. Li C, Li H, Jiang Z, Zhang T, Wang Y, Li Z, Wu Y, Ji S, Xiao S, Ryffel B, Radek KA, Xia Z, Lai Y. Interleukin-33 increases antibacterial defense by activation of inducible nitric oxide synthase in skin. PLoS Pathog. 2014; 10: e1003918.
53. Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010; 11: 889-896.
54. Dubois CM, Blanchette F, Laprise MH, Leduc R, Grondin F, Seidah NG. Evidence that furin is an authentic transforming growth factor-beta1-converting enzyme. Am J Pathol. 2001; 1: 305-316.
55. Al-Mulla F, Leibovich SJ, Francis IM, Bitar MS. Impaired TGF-signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Mol Biosyst. 2011; 7: 3006-3020.
56. Endres K, Anders A, Kojro E, Gilbert S, Fahrenholz F, Postina R. Tumor necrosis factor-converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem. 2003; 270: 2386-2393.
57. Driscoll WS, Vaisar T, Tang J, Wilson CL, Raines EW. Macrophage ADAM17 deficiency augments CD36-dependent apoptotic cell uptake and the linked antiinflammatory phenotype. Circ Res. 2013; 113: 52-61.
58. Pelegrin P, Surprenant A. Dynamics of macrophage polarization reveal new mechanism to inhibit IL-1 release through pyrophosphates. EMBO J. 2009; 28: 2114-2127.
59. Bugge TH, Leppla SH. Anthrax target in macrophages unveiled. Nat Genet. 2006; 38: 137-138.
60. Lin H, Ah Kioon M, Lalou C, Larghero J, Launay J, Khatib A, Cohen-Solal M. Protective role of systemic furin in immune response-induced arthritis. Arthritis Rheum. 2012; 64: 2878-2886.
61. Srour N, Lebel A, McMahon S, Fournier I, Fugère M, Day R, Dubois CM. TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett. 2003; 554: 275-283.
62. Torroella-Kouri M, Silvera R, Rodriguez D, Caso R, Shatry A, Opiela S, Ilkovitch D, Schwendener RA, Iragavarapu-Charyulu V, Cardentey Y, Strbo N, Lopez DM. Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated. Cancer Res. 2009; 69: 4800-9.
63. Taverniti V, Stuknyte M, Minuzzo M, Arioli S, De Noni I, Scabiosi C, Cordova ZM, Junttila I, Hamalainen S, Turpeinen H, Mora D, Karp M, Pesu M, et al. S-layer protein mediates the stimulatory effect of Lactobacillus helveticus MIMLh5 on innate immunity. Appl Environ Microbiol. 2013; 79: 1221-1231.
64. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2014; URL: http://www. R-project.org/.
65. Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43: e47.
66. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000; 28: 27-30.
67. Netea MG, Nold-Petry CA, Nold MF, Joosten LA, Opitz B, van der Meer JH, van de Veerdonk FL, Ferwerda G, Heinhuis B, Devesa I, Funk CJ, Mason RJ, Kullberg BJ, et al. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood. 2009; 113: 2324-2335.
68. McIlwain DR, Lang PA, Maretzky T, Hamada K, Ohishi K, Maney SK, Berger T, Murthy A, Duncan G, Xu HC, Lang KS, Häussinger D, Wakeham A, et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science. 2012; 335: 229-232.